Elan says British pharmaceutical firm Quadrant has agreed to its takeover offer of 75p per share. Elan already owns about 7% of Quadrant.

Quadrant had previously agreed to an offer of 60p per share from US company Inhale Therapeutic, which later said it was considering its position.